Source: Health Products Regulatory Authority (IE) Revision Year: 2011 Publisher: Teva Pharma B.V. Computerweg 10 3542 DR Utrecht Netherlands
Doxorubicin Teva 2 mg/ml Concentrate for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion Clear, red solution. pH = 2.7-3.3 |
1 ml of Doxorubicin Teva 2 mg/ml contains 2 mg doxorubicin hydrochloride 5 ml of Doxorubicin Teva 2 mg/ml contains 10 mg doxorubicin hydrochloride 10 ml of Doxorubicin Teva 2 mg/ml contains 20 mg doxorubicin hydrochloride 25 ml of Doxorubicin Teva 2 mg/ml contains 50 mg doxorubicin hydrochloride 100 ml of Doxorubicin Teva 2 mg/ml contains 200 mg doxorubicin hydrochloride
Excipients: 1 ml of Doxorubicin Teva 2 mg/ml contains 3.54 mg sodium 5 ml of Doxorubicin Teva 2 mg/ml contains 17.7 mg sodium 10 ml of Doxorubicin Teva 2 mg/ml contains 35.4 mg sodium 25 ml of Doxorubicin Teva 2 mg/ml contains 88.5 mg sodium 100 ml of Doxorubicin Teva 2 mg/ml contains 354.1 mg sodium
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Doxorubicin |
Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects. |
| List of Excipients |
|---|
|
Sodium chloride |
Doxorubicin Teva 2 mg/ml concentrate for solution for infusion is supplied in vials of 5 ml (10 mg), 10 ml (20 mg), 25 ml (50 mg) or 100 ml (200 mg) containing a red-orange, clear, sterile solution.
Primary packaging material: Vials with a nominal volume of 5, 10,25 or 100 ml, colourless glass type I (Ph.Eur.), with a chlorobutyl rubber stopper with an inert fluoropolymer (PTFE) coating on the inner side and with an aluminium seal covered with a coloured polypropylene disc.
Trade package quantities: Boxes with one vial of 5, 10,25 or 100 ml.
Not all pack sizes may be marketed.
Teva Pharma B.V.
Computerweg 10
3542 DR
Utrecht
Netherlands
PA 749/83/1
Date of first authorisation: 20th November 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
